Contract 36E79724D0034
Xlcare Pharmaceuticals Inc · Department Of Veterans Affairs · August 15, 2024
Xlcare Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on August 15, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 8, 2025. If all options are exercised, the contract could reach $11.07 million.
Contract details
- PIID
- 36E79724D0034
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 15, 2024
- Latest action
- September 8, 2025
Description
EXERCISE OPTION YEAR 1 FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2025 TO OCT 13, 2025 WITH NO PRICE CHANGES
Modification timeline
-
September 8, 2025Mod P00001 · Exercise An Option$0
-
August 15, 2024Base awardNEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79724D0034?
Contract 36E79724D0034 is a federal contract awarded to Xlcare Pharmaceuticals Inc by Department Of Veterans Affairs on August 15, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36E79724D0034?
Xlcare Pharmaceuticals Inc won contract 36E79724D0034 from Department Of Veterans Affairs.
How much is contract 36E79724D0034 worth?
Contract 36E79724D0034 has obligated $0 to date but carries a potential ceiling of $11.07 million if fully funded and all options are exercised.